Degron Therapeutics

Degron Therapeutics aims to become a global leader in the development of innovative protein degradation drugs, specifically molecular glue-type small molecule new drugs. The Degron team, composed of world-class managers and scientific leaders with international perspectives and extensive industry experience, will provide groundbreaking solutions and pathways in the discovery and validation of novel targets—especially those undruggable by traditional small-molecule inhibitors—as well as in new compound optimization and preclinical and clinical research. These efforts span all therapeutic areas, with the mission of benefiting human health by addressing unmet medical needs that are clinically urgent.